{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:02:50Z","timestamp":1761919370171},"reference-count":16,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T00:00:00Z","timestamp":1285632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p>Interferon\u2010\u03b2 is used in patients with multiple sclerosis to reduce autoimmunity; although other psychiatric side\u2010effects are common, in contrast to interferon\u2010alpha, psychosis has been reported only once. A patient with multiple sclerosis developed auditory hallucinations, paranoid delusions, and increased aggressiveness after 16\u2003months of treatment with interferon\u2010\u03b2\u20101b, 250\u2003\u00b5g every other day. He responded after about one month to antipsychotic treatment, but tended to relapse upon dose reduction, and after 2\u2003years still needs antipsychotics to control his symptoms. Because there was no change in his magnetic resonance imaging between pre\u2010 and post\u2010treatment with interferon, we concluded that psychosis was more related to interferon treatment than to the underlying disease.<\/jats:p>","DOI":"10.1111\/j.1440-1819.2010.02122.x","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T10:01:35Z","timestamp":1285668095000},"page":"584-586","source":"Crossref","is-referenced-by-count":17,"title":["Persistent interferon\u2010\u03b2\u20101b\u2010induced psychosis in a patient with multiple sclerosis"],"prefix":"10.1111","volume":"64","author":[{"given":"Giovanni","family":"Manfredi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio D.","family":"Kotzalidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Sani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia E.","family":"Koukopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Savoja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Lazanio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Girardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Tatarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,9,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00115-001-1224-9"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674370404900302"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.054635"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000095964.34294.B4"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2005.09.013"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200301000-00002"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2005.02.017"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0033-3182(98)71296-4"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2000.957110111.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1C266"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000227348.59912.5d"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(03)00032-4"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.2.226"},{"issue":"3","key":"e_1_2_5_16_2","first-page":"41","article-title":"Mitoxantrone in the treatment of relapsed and refractory acute leukemia","volume":"11","author":"Moore JO","year":"1984","journal-title":"Semin. Oncol."},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2010.02.005"}],"container-title":["Psychiatry and Clinical Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1819.2010.02122.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1819.2010.02122.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T13:59:20Z","timestamp":1697291960000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1819.2010.02122.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,28]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1440-1819.2010.02122.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1819.2010.02122.x","archive":["Portico"],"relation":{},"ISSN":["1323-1316","1440-1819"],"issn-type":[{"value":"1323-1316","type":"print"},{"value":"1440-1819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,28]]}}}